Streptococcus pneumoniae is a common human pathogen that causes an extensive variety of diseases, including pneumonia, bacteremia, and meningitis (16) . In recent years, two new pneumococcal serotypes have been described, serotypes 6C and 6D, and both are due to the modification of a part of the capsular locus in serotypes 6A and 6B, respectively (13, 18) . Data on the epidemiology of serotypes 6C and 6D are still very scarce.
The pediatric 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in Spain in 2001. Since then, a decline in PCV7 serotypes has been observed in association with the fall in antimicrobial nonsusceptibility rates (1, 9) . The increase in serotype 6A detected in the United States (7) and other countries was linked to the emergence of serotype 6C, previously identified as serotype 6A.
The overall incidence of adult invasive pneumococcal disease (IPD) in the 1997-2007 period at our hospital was analyzed in a previous study (1) have been found among carriage (4, 11, 17) or IPD (4, 5, 7, 12) isolates. Although serotype 6C was present before the introduction of PCV7, its proportion rose in the 2004-2008 period, as reported in the United States (5). Table 1 presents the clinical characteristics of serogroup 6 IPD episodes by serotype. The 30-day mortality rate was significantly higher among patients with IPD episodes caused by serotype 6C pneumococci. However, these results should be treated with caution due to the low number of episodes in our series. In contrast to a study carried out in South Africa (7), we did not find any serotype 6C strains causing meningitis. Antimicrobial susceptibility and macrolide resistance genes. The antimicrobial susceptibility was tested by the microdilution method (6) . By comparison of the 1994-1998 and 1999-2003 periods, no significant changes in the antimicrobial susceptibility rates were found, with the exception of a decrease in antimicrobial nonsusceptibility to cefotaxime (P Ͻ 0.05) ( Table 2 ). By comparison of the 1994-1998 and 2004-2008 periods, the antimicrobial nonsusceptibility rates decreased significantly in the latter period. No penicillin-or cefotaxime-resistant strains were found using nonmeningeal breakpoints.
Sixty-two (68.1%) of the serogroup 6 strains were macrolide resistant. Using the disk diffusion method (6), 59 (95.2%) of these showed an MLS B phenotype due to the presence of the erm(B) gene, as detected by PCR (3). The M phenotype was detected in three (4.8%) strains, two carrying the mef(E) gene and one carrying the mef(A) gene (19) .
Penicillin nonsusceptibility was more frequent among serotype 6B (46/47, 97.9%) and 6C (10/16, 62.5%) pneumococci than among 6A isolates (4/28, 14.3%). Macrolide resistance was more frequent in serotypes 6B (100%) and 6A (14/28, 50%) than in 6C (1/16, 6.3%).
Molecular typing. All serogroup 6 isolates were analyzed by pulsed-field gel electrophoresis (PFGE) (15) , and multilocus sequence typing (MLST) was performed with the 84 available strains (8) . When an unusual association between serotype and sequence type (ST) was found, the serotype was confirmed by PCR (5) .
Two sequence types (ST90 and ST1624) accounted for 53.2% (25/47) of serotype 6B pneumococci and were related to the multidrug-resistant clone Spain 6B -ST90 (Fig. 1) -ST90 clone. This has contributed to the overall decrease in penicillin and antibiotic resistance of invasive pneumococci in Spain (1, 9) .
In agreement with a previous report (2), serotype 6A pneumococci were genetically diverse and were less resistant to antibiotics than serotype 6B. The most frequent STs were ST2611 and ST2591, which accounted for 14.3% and 10.7% of the serotype 6A isolates, respectively. Pneumococci of these STs have been identified only in Spain and Italy (http://spneumoniae.mlst.net).
We found high genetic diversity among serotype 6C pneumococci, as published previously (12, 17, 18) . However, 7 of 16 serotype 6C pneumococci shared the same ST (ST224), suggesting a clonal spread. ST224 was first described in serotype 6A pneumococci obtained from a patient with meningitis in 1997 in Spain, which was recently identified as serotype 6C (A. Fenoll, personal communication). Moreover, ST1150 (a singlelocus variant of ST224) was identified as a major lineage among carriage isolates from Portugal (17) and invasive isolates in the north of Spain (14) . Serotype 6C isolates were nonsusceptible mainly to penicillin, in contrast with the study published in South Africa (7) but in agreement with other publications from Portugal (17) and the United States (10).
In conclusion, PCV7 has been highly effective in reducing the prevalence of the invasive 6B serotype. Further studies are needed in order to determine the impact of the introduction of PCV13 on the prevalence of serotypes 6A and 6C.
